«Apple allergens as an effective option for treating apple allergy.» (sciencedaily.com)
Working in close collaboration with Tamar Kinaciyan at MedUni Vienna's Department of Dermatology, a research group led by Barbara Bohle at the Institute of Pathophysiology and Allergy Research has now demonstrated in a Phase II trial that the apple allergen «Mal d 1» significantly reduces the symptoms of apple allergy and is therefore an effective and safe treatment option. (sciencedaily.com)
Of the 60 volunteers with birch pollen - related apple allergy, 20 were treated with placebo, 20 with a birch pollen allergen and with the recombinant apple allergen Mal d 1, that is to say genetically manufactured, reproducible, very stable and therefore easily stored. (sciencedaily.com)